GWI Launches New Office in Singapore, Expands APAC Footprint
17.8.2021 08:28:00 EEST | Business Wire | Press release
GWI, the leading target audience company, today announces the opening of its first APAC office this October in Singapore.
Currently headquartered in London with offices in New York, Prague and Athens, the new Singapore office will position GWI as leading providers of world class research capabilities and solid insights to companies in the APAC region.
Tom Smith, CEO and Founder of GWI explains: “We are powering a world where every business knows its audience. We need to build our presence on the ground in the Asia Pacific to take advantage of the region’s rapidly growing business opportunities. APAC currently represents 20% of our accounts, worth £1.275bn, and has the largest compound annual growth rate (CAGR). Since 2017, APAC has experienced the fastest growth of any region with CAGR in excess of 35%.
“What’s more, our own data* tells us that 71% of professionals in APAC agree that being able to adapt quickly is critical to their company’s long term success. Over a third (34%) of decision-makers in APAC say that keeping up with the latest trends is one of their main considerations for bringing in a new product or service. So we know the businesses in the region are in need of fresh data to help them make critical decisions, and by setting up an office in the region we can enable them to focus on what matters, find the best ideas and then make them happen.
“What’s more, over a third (37%)* of professionals in APAC say that understanding their customer or client audience is one of the biggest challenges their company faces, making it their fourth biggest challenge out of a list of about 25 challenges. This really highlights the need for robust, reliable consumer data. Interestingly, this is highest among business professionals in India and Singapore. Creating a presence on the ground will therefore help us to stay ahead of the ever-changing needs of our customers operating in the region.”
Singapore is well positioned to act as a launchpad for high growth, low penetration markets such as China, Japan and Australia. GWI already works extensively with businesses in the APAC region, especially New Zealand and Australia.
Tom continues: “Significantly, we are increasingly asked for local support by some of our biggest clients, from independent agencies to corporate brands. We therefore decided this is the perfect time to expand our company and open an office in Singapore. By putting a team in Singapore, we will be able to overcome any language, cultural, network and timezone challenges whilst accelerating APAC growth.”
The APAC office will initially be staffed by a combination of relocated European team members and locally sourced talent. The open job positions can be viewed here. The expansion into APAC will allow GWI to realise continued growth in the years to come following its successes in 2020 where the company signed over 200 new enterprise customers and posted more than 40% growth in annual recurring revenue.
ENDS
Notes to editors
*Source: Q2 2020 Wave of GWI Work data
About GWI
GWI is the leading supplier of target audience insight to the global marketing industry.
Trusted by the world’s biggest brands, media organizations, and agencies on a daily basis to get closer to their audiences, the company’s flagship survey represents over 2 billion people globally. Using the subscription-based platform, clients like Twitter, Google, Spotify, WPP, IPG, and Omnicom Group gather in-depth insights into behaviors, attitudes, and interests in seconds through a combination of survey data and analytics.
Among a range of leading data products available alongside its flagship survey are:
- GWI USA is a deep dive into the habits, behaviors and attitudes of 240m internet users in the USA.
- GWI Gaming delves into the actions and attitudes of gamers across 15 markets.
- GWI Sports investigates sports fandom and participation across 15 markets.
- GWI Kids gets to the heart of how kids actually think, so you can be sure to kid-proof your ideas and concepts from here on.
- GWI Work gives a detailed view of the lives of business professionals across 10 markets.
- GWI Zeitgeist, included with our core survey, is fielded monthly and zeroes in on the stuff that matters. It’s topical, timely, and relevant.
Those looking for even more bespoke research solutions can enrich GWI data with a range of services like hyper-targeted custom surveys, brand trackers, and recontact studies.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210816005768/en/
Contact information
Press:
Liam Rawson
Hotwire Global
gwi@hotwireglobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 02:00:00 EEST | Press release
Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for people living with FOP, bringing a new treatment option to adult and pediatric patients living with this devastating disease,” said Chris Peetz, Chief Executive Officer at Mirum. “At Mirum, we are driven to serve rare disease communities where the unmet need is significant and the opportunity to make a difference is profound. The approval of Atebrioz reflects what can be achieved when industry, researchers
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 22:19:00 EEST | Press release
At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where Digital Reef will purchase verified environmental assets generated by Oreasoc, supporting the development of low-carbon data centres mitigating their environmental footprint through the protection of high-integrity natural ecosystems across the South American Amazon, whilst advancing sustainable economic development. AI and data centre demand is driving rapid growth, with the International Energy Agency project
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 16:00:00 EEST | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata from data and enables metadata services to scale independently, creating a foundation for AI infrastructure capable of supporting trillions of files, exabyte-scale environments, and massively pa
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 15:57:00 EEST | Press release
MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity, technology, infrastructure, execution, market access and tailored client solutions within an integrated financial ecosystem. The second award acknowledg
Croma-Pharma Introduces saypha ® volume prime Lidocaine25.9.2026 15:04:00 EEST | Press release
Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine, Croma-Pharma further strengthens its product range, reflecting the company's long-standing commitment to scientific excellence and continuous product innovation, and provid
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
